DE602007013110D1 - Verfahren zum nachweis eines analyten in einer biologischen matrix - Google Patents

Verfahren zum nachweis eines analyten in einer biologischen matrix

Info

Publication number
DE602007013110D1
DE602007013110D1 DE602007013110T DE602007013110T DE602007013110D1 DE 602007013110 D1 DE602007013110 D1 DE 602007013110D1 DE 602007013110 T DE602007013110 T DE 602007013110T DE 602007013110 T DE602007013110 T DE 602007013110T DE 602007013110 D1 DE602007013110 D1 DE 602007013110D1
Authority
DE
Germany
Prior art keywords
analyte
detecting
biological matrix
sample
dilution buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013110T
Other languages
English (en)
Inventor
Michael Adler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chimera Biotec GmbH
Original Assignee
Chimera Biotec GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38462758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602007013110(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chimera Biotec GmbH filed Critical Chimera Biotec GmbH
Publication of DE602007013110D1 publication Critical patent/DE602007013110D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
DE602007013110T 2007-04-04 2007-04-04 Verfahren zum nachweis eines analyten in einer biologischen matrix Active DE602007013110D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/053323 WO2008122310A1 (en) 2007-04-04 2007-04-04 Method for the detection of an analyte in biological matrix

Publications (1)

Publication Number Publication Date
DE602007013110D1 true DE602007013110D1 (de) 2011-04-21

Family

ID=38462758

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013110T Active DE602007013110D1 (de) 2007-04-04 2007-04-04 Verfahren zum nachweis eines analyten in einer biologischen matrix

Country Status (6)

Country Link
US (1) US20100291562A1 (de)
EP (1) EP2132339B1 (de)
AT (1) ATE501280T1 (de)
DE (1) DE602007013110D1 (de)
DK (1) DK2132339T3 (de)
WO (1) WO2008122310A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008047790A1 (de) * 2008-09-17 2010-04-15 Qiagen Gmbh Verfahren zur Normierung des Gehalts von Biomolekülen in einer Probe
CA2749041C (en) 2008-12-31 2019-09-03 Abbott Point Of Care Inc. Method and device for immunoassay using obligonucleotide conjugates
AU2010306862B2 (en) 2009-10-13 2015-08-27 Nanostring Technologies, Inc. Protein detection via nanoreporters
GB201011971D0 (en) 2010-07-15 2010-09-01 Olink Ab Methods and product
JP5852334B2 (ja) * 2011-06-07 2016-02-03 株式会社日立ハイテクノロジーズ 自動分析方法
DE102014010333A1 (de) 2014-07-14 2016-01-14 Qiagen Gmbh Verfahren zum Nachweis wenigstens eines Zielanalyten in einer Probe
WO2016099999A1 (en) * 2014-12-18 2016-06-23 Ge Healthcare Uk Limited Analyte detection on a solid support by nucleic acid amplification coupled to an immunoassay
RU2018107453A (ru) 2015-08-10 2019-09-12 Эссенликс Корп. Устройства для анализов и способы в биологии/химии, предусматривающие упрощенные стадии, образцы небольшого объема, повышенную скорость и простоту применения
CN108633304B (zh) 2015-09-14 2020-08-14 艾森利克斯公司 采集分析蒸汽凝析,特别是呼出气凝析的装置与系统,以及使用方法
EP3341728A4 (de) 2015-09-14 2019-04-17 Essenlix Corp. Vorrichtung und system zur analyse einer probe, insbesondere blut, sowie verfahren zu deren verwendung
EP3558121B1 (de) 2016-12-21 2022-06-08 Essenlix Corporation Vorrichtungen und verfahren zur authentifizierung einer probe und verwendung davon
EP3579981A4 (de) 2017-02-07 2021-03-31 Essenlix Corporation Komprimierter open-flow-test und verwendung
CN111316096B (zh) 2017-02-08 2023-08-11 Essenlix公司 生物/化学材料提取和测定
US11940382B2 (en) 2017-02-09 2024-03-26 Essenlix Corporation Assay with amplification
US11883824B2 (en) 2017-02-09 2024-01-30 Essenlix Corporation Assay using different spacing heights
WO2018148609A2 (en) 2017-02-09 2018-08-16 Essenlix Corporation Colorimetric assays
CN111448449A (zh) 2017-02-16 2020-07-24 Essenlix公司 采用纹理化表面的测定
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
WO2019028133A1 (en) 2017-08-01 2019-02-07 Essenlix Corporation DEVICES AND METHODS FOR EXAMINING THE EFFECTS OF MEDICINE ON MICROORGANISMS
CN111492222A (zh) 2017-08-01 2020-08-04 Essenlix公司 样品收集、保持和测定
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US11648551B2 (en) 2017-12-12 2023-05-16 Essenlix Corporation Sample manipulation and assay with rapid temperature change
WO2019118936A2 (en) 2017-12-14 2019-06-20 Essenlix Corporation Devices, systems, and methods for monitoring hair
WO2019140334A1 (en) 2018-01-11 2019-07-18 Essenlix Corporation Homogeneous assay (ii)
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
KR970002255B1 (ko) * 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
US5496938A (en) * 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
ES2113940T3 (es) * 1990-12-03 1998-05-16 Genentech Inc Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
WO1992015708A1 (en) * 1991-02-27 1992-09-17 Amoco Corporation Methods for improving the sensitivity of hybridization assays
EP0580737B1 (de) * 1991-04-10 2004-06-16 The Scripps Research Institute Bibliotheken heterodimerer rezeptoren mittels phagemiden
US5733743A (en) * 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
AU689755B2 (en) * 1992-09-22 1998-04-09 Biofocus Discovery Limited Recombinant viruses displaying a nonviral polypeptide on their external surface
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US5496398A (en) * 1994-10-28 1996-03-05 Thiele Kaolin Company Reduction of microorganisms in kaolin clay slurries
US5702892A (en) * 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
US6665317B1 (en) * 1999-10-29 2003-12-16 Array Telecom Corporation Method, system, and computer program product for managing jitter
EP1660858A4 (de) * 2003-07-21 2007-10-24 Amplified Proteomics Inc Multiplex-analytnachweis

Also Published As

Publication number Publication date
US20100291562A1 (en) 2010-11-18
ATE501280T1 (de) 2011-03-15
EP2132339A1 (de) 2009-12-16
WO2008122310A1 (en) 2008-10-16
EP2132339B1 (de) 2011-03-09
DK2132339T3 (da) 2011-06-27

Similar Documents

Publication Publication Date Title
ATE501280T1 (de) Verfahren zum nachweis eines analyten in einer biologischen matrix
CL2011002228A1 (es) Aparato para el analisis integrado de acidos nucleicos en tiempo real, y metodo de detecicion de dichas moleculas.
BR112017021256A2 (pt) dispositivos e métodos para a análise de amostras
ATE479780T1 (de) Qpcr unter verwendung eines ionen-sensitiven feldeffekt-transistors zur ph-messung
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
BRPI0814202A2 (pt) Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
ZA201403386B (en) A method of detecting and/or quantifying an analyte in a biological sample
DE502006006367D1 (de) Verfahren zum messen einer analytkonzentration in
ATE519107T1 (de) Verfahren zur tacrolimus-extraktion und - quantifizierung unter verwendung wässriger detergentien
MY170164A (en) Aptamer-based multiplexed assays
GB2458855A (en) Detection device and methods of use
EA201071134A1 (ru) Анализ днк посредством капиллярного электрофореза
DE602009001116D1 (de) Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung
ATE541216T1 (de) Fluoreszenztestverfahren
WO2009057695A1 (ja) 遺伝子解析による腺腫又はがんの検出方法
WO2009049007A3 (en) Compositions, methods and systems for rapid identification of pathogenic nucleic acids
EP2693213A4 (de) Erkennungsverfahren durch immunchromatographie zur bestimmung einer probe als fehlprobe ohne zusatz eines prüfmittels und teststreifen zur verwendung in diesem verfahren
IN2014KN01352A (de)
WO2015059487A3 (en) Detection of cleavage activity of an enzyme
AT10236U2 (de) Messanordnung und verfahren zur erfassung von messdaten
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
EP2596121A4 (de) Verfahren zur verknüpfung der ergebnisse von diagnosetests an einem point of care mit laborbasierten verfahren
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2013121368A3 (en) A process for detection and optional quantification of an analyte